Galux raises $29M Series B to scale AI-driven protein design for drug discovery
Galux is building something that drug discovery has chased for decades: the ability to design therapeutic proteins from scratch with speed, accuracy, and confidence. On Monday, the South Korea–based biotech startup said it has raised $29 million in a Series […]